Fluticasone/Salmeterol Shortage Update: What Patients Need to Know in 2026

The Fluticasone/Salmeterol Shortage in 2026: What's Really Going On

If you've had trouble getting your Fluticasone/Salmeterol inhaler filled recently, you're experiencing what thousands of patients across the country are dealing with. Supply disruptions for this critical asthma and COPD medication have left many people calling pharmacy after pharmacy, looking for answers.

In this post, we'll break down the current state of the Fluticasone/Salmeterol shortage, explain what's causing it, and give you clear steps to get your medication.

Is Fluticasone/Salmeterol Still in Shortage?

As of early 2026, yes — certain formulations of Fluticasone/Salmeterol remain in limited supply. The American Society of Health-System Pharmacists (ASHP) has tracked shortages affecting specific generic dry powder inhaler products. However, the shortage is not uniform:

• Wixela Inhub (the generic Advair Diskus by Viatris) has seen intermittent supply issues at some pharmacies and certain strengths
• Advair Diskus (brand name by GSK) may be available at some locations but at significantly higher cost
• AirDuo RespiClick (by Teva) and Advair HFA (the MDI version) have generally been less affected

The shortage has been uneven — some areas of the country are hit harder than others, and availability can change week to week. The best way to check current stock near you is to use Medfinder.

Why Is Fluticasone/Salmeterol Hard to Find?

Several factors are contributing to the ongoing supply challenges:

Complex Manufacturing

Dry powder inhalers are among the most technically difficult medications to manufacture. They require specialized equipment, precise drug-particle sizing, and rigorous quality testing. Even minor production issues can halt supply for weeks.

Few Manufacturers

Only a handful of companies produce Fluticasone/Salmeterol inhalers. When generics were first approved in 2019, the hope was that competition would increase supply. But the complexity of inhaler manufacturing has limited the number of new entrants.

Rising Demand

Asthma affects over 25 million Americans, and COPD affects more than 16 million. As awareness and diagnosis rates improve, more patients need combination inhalers — and supply hasn't kept pace.

Supply Chain Pressures

Broader pharmaceutical supply chain issues — including raw material sourcing and propellant availability for metered-dose inhalers — have rippled through the inhaler market. For a deeper dive, see our post on why Fluticasone/Salmeterol is so hard to find.

How Much Does Fluticasone/Salmeterol Cost in 2026?

Cost remains a significant concern, especially during a shortage when patients may need to look beyond their preferred pharmacy or formulation.

• Brand-name Advair Diskus: $250–$500+ for a 30-day supply without insurance
• Wixela Inhub (generic): $60–$225 without insurance; as low as $64 with a GoodRx coupon
• AirDuo RespiClick: $60–$200 with discount coupons
• Advair HFA: $300–$550 for brand name

If cost is a barrier, read our full guide on how to save money on Fluticasone/Salmeterol, including coupons, manufacturer savings programs, and patient assistance options.

Are There New Options for Patients in 2026?

While no entirely new Fluticasone/Salmeterol products have launched recently, patients do have more choices than a few years ago:

• Generic availability continues to expand: Wixela Inhub remains the primary generic option, and competition may bring additional generics to market.
• Alternative ICS/LABA inhalers: Symbicort (Budesonide/Formoterol) now has generic versions available, making it a more affordable alternative. Breo Ellipta offers once-daily convenience.
• Digital inhalers: The AirDuo Digihaler includes a built-in sensor that tracks your inhaler usage — helpful for patients and doctors managing adherence.
• Telehealth access: More doctors are prescribing inhalers via telehealth, making it easier to get a prescription adjusted without an in-person visit. Learn how to find a doctor who can prescribe Fluticasone/Salmeterol.

How to Find Fluticasone/Salmeterol in Stock Right Now

Here's your action plan:

1. Check Medfinder: Go to medfinder.com and search for Fluticasone/Salmeterol to see real-time pharmacy availability near you.
2. Ask about all versions: If one formulation is out, ask about Wixela Inhub, AirDuo RespiClick, or Advair HFA.
3. Try independent pharmacies: They often have stock when chains don't.
4. Consider mail-order: Mail-order pharmacies may have better access to medications in short supply.
5. Don't wait: Refill 7–10 days before you run out.

For a complete list of strategies, see our guide on how to find Fluticasone/Salmeterol in stock near you.

What About Alternatives?

If you truly can't find any Fluticasone/Salmeterol formulation, several other ICS/LABA inhalers may work for you:

• Symbicort (Budesonide/Formoterol) — generic available, fast-acting LABA component
• Breo Ellipta (Fluticasone/Vilanterol) — once daily, same fluticasone base
• Dulera (Mometasone/Formoterol) — asthma approved, generic available

Read our full comparison in alternatives to Fluticasone/Salmeterol.

Final Thoughts

The Fluticasone/Salmeterol shortage in 2026 is real, but it doesn't have to leave you without your medication. Stay proactive — use Medfinder to check availability, keep your doctor informed, and know your options. Whether that means switching pharmacies, trying a different formulation, or exploring an alternative inhaler, the most important thing is that you keep breathing well.